Matthew D Marsden

7PUBLICATIONS
18CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Nanotoxicology, health and safetyMolecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 20, 2026
PKC inhibitors reveal PKC isoforms involved in HIV latency reversal and immunomodulation.

|Feb 06, 2026
Leveraging HIV-Specific CAR T Cells and Rapamycin Treatment in "Kick-and-Kill" HIV Cure Approaches.

Nishad S Maggirwar, José A Morán, Wenli Mu

|Jan 24, 2025
Synthesis and preclinical evaluation of tigilanol tiglate analogs as latency-reversing agents for the eradication of HIV.

Zachary O Gentry, Owen D McAteer, Jennifer L Hamad

|Jul 27, 2024
HIV Persistence, Latency, and Cure Approaches: Where Are We Now?

Tessa C Chou, Nishad S Maggirwar, Matthew D Marsden

|Apr 22, 2020
Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy.

Clayton Hardman, Stephen Ho, Akira Shimizu

|Apr 08, 2020
Benefits and limitations of humanized mice in HIV persistence studies.

Matthew D Marsden

Pageof 2

Frequent Collaborators

3 joint publications

Jose A Moran

2 joint publications

Thomas D Zaikos

2 joint publications

Jerome A Zack

2 joint publications

Tessa Chou